Eledon Pharmaceuticals, Inc.ELDNNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank38
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P38
Within normal range
vs 5Y Ago
-2.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-17.96%
2024-64.13%
2023-8.09%
2022-7.90%
2021-177.55%
20206.35%
2019-0.88%
2018-7.16%
201765.58%
201615.77%